SCHEMBL845228

SCHEMBL845228

CSCC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)CSC)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.49
HCRTR2 O43614 2/20 0.49
ALDH1A1 P00352 3/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPC1 O15118 1/20 0.47
PABPC1 P11940 1/20 0.46
HTT P42858 2/20 0.46
MAPK1 P28482 2/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.44
KDM4E B2RXH2 1/20 0.44
TSHR P16473 1/20 0.43
EP300 Q09472 1/20 0.43
CREBBP Q92793 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845591 0.91 HCRTR1 (0.49) HCRTR1HCRTR2ALDH1A1CYP2C9CYP2C19
SCHEMBL845251 0.88 PABPC1 (0.50) ALDH1A1CYP2C9CYP2C19NPC1PABPC1
SCHEMBL845288 0.87 MAPK1 (0.51) HCRTR1HCRTR2ALDH1A1CYP2C9CYP2C19
SCHEMBL13272186 0.87 MAPK1 (0.51) HCRTR1HCRTR2ALDH1A1CYP2C9CYP2C19
SCHEMBL845250 0.87 HCRTR1 (0.46) HCRTR1HCRTR2ALDH1A1CYP2C9CYP2C19
SCHEMBL13865067 0.86 HCRTR1 (0.62) HCRTR1HCRTR2ALDH1A1CYP2C9CYP2C19
SCHEMBL845231 0.86 HCRTR1 (0.43) HCRTR1HCRTR2ALDH1A1CYP2C9CYP2C19
SCHEMBL844899 0.86 NPC1 (0.52) ALDH1A1CYP2C9CYP2C19NPC1PABPC1
SCHEMBL844965 0.85 VHL (0.44) HCRTR1HCRTR2ALDH1A1CYP2C9CYP2C19
SCHEMBL844902 0.85 ALDH1A1 (0.47) HCRTR1HCRTR2ALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed